Document 2979
 DOCN  M94A2979
 TI    Oral candidiasis, the steady partner's treatment.
 DT    9412
 AU    Rosello X; Lopez J; Jane E; University of Barcelona, Spain.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):181 (abstract no. PB0150). Unique
       Identifier : AIDSLINE ICA10/94369596
 AB    OBJECTIVES: To determine the importance of treating the steady couple of
       HIV (+) patients to prevent the oral candidiasis recurrences. METHODS:
       70 HIV (+) patients with CD4 levels < 300 were studied during 1 year. 30
       patients are inmates of a penitentiary (GROUP A) The other two groups
       had safe sexual intercourse with the steady partner. After presenting
       oral candidiasis they were treated with Ketokonazole. The steady
       partners of 20 of these patients having sexual contact were treated
       simultaneously with the same therapeutic protocol (GROUP C). The
       response to the treatment and the number of recurrences have been
       studied. The results have been analyzed with the ANOVA test. RESULTS: A
       significant statistic difference can be observed between groups A/C with
       B, for the average of recurrences. And the resistences. The response to
       the treatment was good in all groups. DISCUSSION AND CONCLUSIONS: More
       and more studies reflecting the antifungals resistances are published.
       By us the oral candidiasis be haves in the similar way to vaginal
       candidiasis, for what we think it would also benefit from the
       simultaneous treatment of the steady partner.
 DE    AIDS-Related Opportunistic Infections/*DRUG THERAPY/TRANSMISSION
       Candidiasis, Oral/*DRUG THERAPY/TRANSMISSION  Female  Human
       Ketoconazole/*THERAPEUTIC USE  Male  Microbial Sensitivity Tests
       Recurrence  *Sexual Partners  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).